Cargando…
History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930031/ http://dx.doi.org/10.1016/S2666-6367(22)00592-9 |
| _version_ | 1784670973728915456 |
|---|---|
| author | Djulbegovic, Mia Gevorgian, Melinda Luning-Prak, Eline Garfall, Alfred L. Vogl, Dan T. Cohen, Adam D. Waxman, Adam Susanibar, Sandra Stadtmauer, Edward A. |
| author_facet | Djulbegovic, Mia Gevorgian, Melinda Luning-Prak, Eline Garfall, Alfred L. Vogl, Dan T. Cohen, Adam D. Waxman, Adam Susanibar, Sandra Stadtmauer, Edward A. |
| author_sort | Djulbegovic, Mia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8930031 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89300312022-03-18 History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies Djulbegovic, Mia Gevorgian, Melinda Luning-Prak, Eline Garfall, Alfred L. Vogl, Dan T. Cohen, Adam D. Waxman, Adam Susanibar, Sandra Stadtmauer, Edward A. Transplant Cell Ther Poster Session - Health Services American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930031/ http://dx.doi.org/10.1016/S2666-6367(22)00592-9 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session - Health Services Djulbegovic, Mia Gevorgian, Melinda Luning-Prak, Eline Garfall, Alfred L. Vogl, Dan T. Cohen, Adam D. Waxman, Adam Susanibar, Sandra Stadtmauer, Edward A. History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies |
| title | History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies |
| title_full | History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies |
| title_fullStr | History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies |
| title_full_unstemmed | History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies |
| title_short | History of Autologous SCT Does Not Appear to Blunt the Serologic Response to COVID-19 Vaccination for Patients with Lymphoid Malignancies |
| title_sort | history of autologous sct does not appear to blunt the serologic response to covid-19 vaccination for patients with lymphoid malignancies |
| topic | Poster Session - Health Services |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930031/ http://dx.doi.org/10.1016/S2666-6367(22)00592-9 |
| work_keys_str_mv | AT djulbegovicmia historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT gevorgianmelinda historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT luningprakeline historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT garfallalfredl historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT vogldant historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT cohenadamd historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT waxmanadam historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT susanibarsandra historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies AT stadtmaueredwarda historyofautologoussctdoesnotappeartoblunttheserologicresponsetocovid19vaccinationforpatientswithlymphoidmalignancies |